Testing effectiveness (Phase 2)Study completedNCT02858310
What this trial is testing
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Who this might be right for
Papillomavirus InfectionsCervical Intraepithelial NeoplasiaCarcinoma In Situ+2 more
National Cancer Institute (NCI) 219